MARC details
000 -LEADER |
fixed length control field |
02444nam a22003977a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
221018s20222022 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
2214-2509 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1016/j.idcr.2022.e01616 [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
PMC9472058 [pmc] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
S2214-2509(22)00244-X [pii] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
36119758 |
245 ## - TITLE STATEMENT |
Title |
A mild, self-resolving case of Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis. |
251 ## - Source |
Source |
IDCases. 30:e01616, 2022. |
252 ## - Abbreviated Source |
Abbreviated source |
IDCases. 30:e01616, 2022. |
253 ## - Journal Name |
Journal name |
IDCases |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2023 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
epublish |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Medline status |
PubMed-not-MEDLINE |
266 ## - Date added to catalog |
Date added to catalog |
2022-10-20 |
520 ## - SUMMARY, ETC. |
Abstract |
Hemophagocytic lymphohistiocytosis (HLH) is a multisystem disease caused by an excessive activation of the immune system. In most instances, HLH can be fatal without treatment; a life-threatening syndrome driven by a dysregulated immune system and activation of macrophages resulting in cytokine release and consequent cellular damage. HLH can occur as a consequence of multiple genetic abnormalities or environmental triggers. We present an interesting case of mild, self-resolving, HLH due to Epstein-Barr Virus (EBV) infection in a young woman. The best-known diagnostic criteria are based on the HLH-2004 trial, incorporating either the presence of known mutations or five of eight clinical and laboratory findings. Prompt initiation of etoposide-containing therapy is associated with improved survival. Rituximab, an anti-CD20 antibody, can also remove EBV-harboring B-cells and improve outcomes. In a rare subset of patients, the disease can spontaneously resolve without any therapeutic interventions thus sparing the patients from toxic therapies. Copyright © 2022 The Authors. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Franklin Square Medical Center |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Union Memorial Hospital |
656 ## - INDEX TERM--OCCUPATION |
Department |
Hospitalist |
656 ## - INDEX TERM--OCCUPATION |
Department |
Internal Medicine Residency |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Case Reports |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Adhikari, Biplov |
Institution Code |
MUMH |
Program |
Internal Medicine Residency |
Degree |
MBBS |
Resident year |
Resident PGY 2 |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Haas, Christopher |
Institution Code |
MUMH |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Rao, Shiavax |
Institution Code |
MUMH |
Program |
Internal Medicine Residency |
Degree |
MD |
Resident year |
Resident PGY 3 |
790 ## - Authors |
All authors |
Adhikari B, Haas CJ, Rao SJ |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1016/j.idcr.2022.e01616">https://dx.doi.org/10.1016/j.idcr.2022.e01616</a> |
Public note |
https://dx.doi.org/10.1016/j.idcr.2022.e01616 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |